PHIOPhio Pharmaceuticals Corp.

$13M

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$23,000

Gross Profit

-$1M-5817.4% margin

Operating Income

-$2M-9734.8% margin

Net Income

-$2M-9734.8% margin

EPS (Diluted)

$-5337.70

QoQ Revenue Growth

+53.3%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$41,000

Balance Sheet

Total Assets

$3M

Total Liabilities

$3M

Stockholders' Equity

$567,000

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$23,000	$0	—
Gross Profit	-$1M	-$1M	+0.7%
Operating Income	-$2M	-$5M	+59.0%
Net Income	-$2M	-$5M	+59.0%

PHIO Q1 2018 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena